Shengyun Cai
Overview
Explore the profile of Shengyun Cai including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
112
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Linn Z, Gu Z, Wang L, Cai S
Int Med Case Rep J
. 2025 Feb;
18:241-248.
PMID: 39959715
Ovarian cancer remains a significant cause of morbidity and mortality in women worldwide. Olaparib, a poly ADP-ribose polymerase (PARP) inhibitor, has been shown in studies to increase the time that...
2.
Qi R, Guan R, Cai S, Xu M, Yang W, Wang C
Front Genet
. 2023 Oct;
14:1246725.
PMID: 37854057
To evaluate the dynamic expression profiling alterations of SARS-CoV-2-associated molecules within the fertile human endometrium throughout the menstrual cycle. Furthermore, to explore the inherent vulnerability of the endometrium to SARS-CoV-2...
3.
Xia L, Wang Y, Cai S, Xu M
J Immunol Res
. 2021 Jun;
2021:6636791.
PMID: 34095320
Background: Ovarian cancer is the most fatal gynecological malignancy. Owing to its insidious onset, rapid development, and poor prognosis, ovarian cancer is the fifth most common cause of death in...
4.
Cai S, Yu X, Gu Z, Yang Q, Wen B, Sheng J, et al.
Arch Gynecol Obstet
. 2020 Apr;
301(5):1275-1287.
PMID: 32274635
Purpose: Cervical cancer (CC) patients usually have poor prognosis. The present study aims to find a DNA methylation signature for predicting survival of CC patients. Methods: We selected CC patients...
5.
Xia L, Wang H, Cai S, Su X, Shen J, Meng Q, et al.
Front Oncol
. 2018 Sep;
8:368.
PMID: 30237984
Given the high morbidity and the trend of younger individuals being affected observed in cervical cancer, it is important to identify sensitive and effective biomarkers for predicting the survival outcome...
6.
Cai S, Zhang P, Dong S, Li L, Cai J, Xu M
Cell Physiol Biochem
. 2018 Feb;
45(3):1061-1071.
PMID: 29439245
Background/aims: Ovarian cancer (OC) is the fifth leading cause of cancer-related death in women, and it is difficult to diagnose at an early stage. The purpose of this study was...
7.
Guan R, Cai S, Sun M, Xu M
Oncol Lett
. 2017 Sep;
14(3):3155-3161.
PMID: 28927060
Ovarian cancer is the most common gynecological malignant cancer in female genitalia. Dysregulation or dysfunction of microRNAs (miRs) contribute to cancer development. The role of miR-520b in ovarian cancer remains...
8.
Li L, Cai S, Liu S, Feng H, Zhang J
J Ovarian Res
. 2017 Apr;
10(1):27.
PMID: 28407786
Background: Ovarian cancer (OC) is a gynecological oncology that has a poor prognosis and high mortality. This study is conducted to identify the key genes implicated in the prognosis of...
9.
Chen Y, Cai S, Wang J, Xu M
Int J Mol Med
. 2015 Jul;
36(3):725-32.
PMID: 26135543
Endometriosis is a common type of estrogen‑dependent, gynecological and chronic inflammatory disease. Epigenetics refers to changes in gene expression that occur without altering the DNA sequence or DNA content. Histone...
10.
Liu C, Zhou C, Gao F, Cai S, Zhang C, Zhao L, et al.
Int J Biol Sci
. 2011 Mar;
7(2):221-33.
PMID: 21448283
MiR-34a, a direct target of p53, has shown to exert potent anti-proliferative effects. It has also been found that miR-34a can be induced by irradiation in vitro and in vivo....